Contact
searchSearch
HMP Global

Psoriasis Topic Center

Featured

psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
psoriasis
News
Visceral Adiposity Linked to Psoriasis Risk, With Inflammation as Partial Mediator
03/11/2026
Jessica Garlewicz
Higher body roundness index, a measure of visceral adiposity, is associated with increased psoriasis prevalence, and systemic immune activation may partially mediate this relationship.
Higher body roundness index, a measure of visceral adiposity, is associated with increased psoriasis prevalence, and systemic immune activation may partially mediate this relationship.
Higher body roundness index, a...
03/11/2026
The Dermatologist
psoriasis
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
MicroRNA Networks Identified as Central Regulators in Psoriasis Pathogenesis
03/03/2026
Jessica Garlewicz
Psoriasis is driven by sustained inflammation and abnormal keratinocyte proliferation.
Psoriasis is driven by sustained inflammation and abnormal keratinocyte proliferation.
Psoriasis is driven by sustained...
03/03/2026
The Dermatologist
psoriasis
News
Psychometric Study Highlights Gender Differences and Psychological Burden in Psoriasis
02/03/2026
Jessica Garlewicz
The findings reinforce the need for dermatologists to address mental health alongside physical disease severity.
The findings reinforce the need for dermatologists to address mental health alongside physical disease severity.
The findings reinforce the need...
02/03/2026
The Dermatologist
psoriasis
News
Obesity Measures Linked to Psoriasis Risk in Patients With Type 2 Diabetes, Nationwide Study Finds
02/03/2026
Jessica Garlewicz
The findings provide new insight into how obesity-related factors may influence psoriasis risk in a population already predisposed to metabolic and inflammatory comorbidities.
The findings provide new insight into how obesity-related factors may influence psoriasis risk in a population already predisposed to metabolic and inflammatory comorbidities.
The findings provide new insight...
02/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Psoriasis Linked to Increased Atherosclerotic Risk Regardless of Arthritis Status
02/03/2026
Jessica Garlewicz
The findings reinforce psoriasis as a systemic inflammatory disease with cardiovascular implications that extend beyond joint involvement.
The findings reinforce psoriasis as a systemic inflammatory disease with cardiovascular implications that extend beyond joint involvement.
The findings reinforce psoriasis...
02/03/2026
The Dermatologist
psoriasis
News
Real-World Registry Data Identify Predictors of Biologic Switching in Psoriasis Care
01/22/2026
Jessica Garlewicz
A new analysis from the CorEvitas Psoriasis Registry highlights baseline clinical and patient-reported features associated with switching biologic therapies in real-world practice, offering insights to support earlier, shared decision-making.
A new analysis from the CorEvitas Psoriasis Registry highlights baseline clinical and patient-reported features associated with switching biologic therapies in real-world practice, offering insights to support earlier, shared decision-making.
A new analysis from the...
01/22/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
psoriasis
News
Metabolic Bariatric Surgery Linked to Psoriasis Improvement, With Response Varying by Procedure Type
01/15/2026
Jessica Garlewicz
Metabolic bariatric surgery (MBS) was associated with improvements in psoriasis severity, quality of life, and treatment burden, according to a systematic review evaluating outcomes in patients with psoriasis and obesity. However, response...
Metabolic bariatric surgery (MBS) was associated with improvements in psoriasis severity, quality of life, and treatment burden, according to a systematic review evaluating outcomes in patients with psoriasis and obesity. However, response...
Metabolic bariatric surgery...
01/15/2026
The Dermatologist

News & FDA Alerts

psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
psoriasis
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
psoriasis
News
Study Links Hypothyroidism to Psoriasis, Independent of Disease Severity
09/02/2025
Jessica Garlewicz
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that...
09/02/2025
The Dermatologist
psoriasis
News
Beta-Blockers Not Linked to Increased Psoriasis Risk, Study Finds
09/02/2025
Jessica Garlewicz
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis...
09/02/2025
The Dermatologist
psoriasis
News
Study Finds Distinct Psychosocial Burdens in Early- vs Late-Onset Psoriasis
08/14/2025
Jessica Garlewicz
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study...
08/14/2025
The Dermatologist
psoriasis
News
Study Highlights Emerging Role of Stem Cells in Psoriasis Pathogenesis
08/14/2025
Jessica Garlewicz
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally...
08/14/2025
The Dermatologist
psoriasis
News
Comorbidity Patterns in Moderate-to-Severe Psoriasis Highlight Need for Integrated Clinical Management
07/22/2025
Jessica Garlewicz
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity...
07/22/2025
The Dermatologist
psoriasis
News
Early Use of Biologics in Psoriasis May Alter Inflammatory Course, Improve Comorbidities
07/10/2025
Jessica Garlewicz
As the understanding of psoriasis pathophysiology continues to evolve, treatment goals may need to expand accordingly.
As the understanding of psoriasis pathophysiology continues to evolve, treatment goals may need to expand accordingly.
As the understanding of...
07/10/2025
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
FDA Alerts
FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients
03/18/2026
Jessica Garlewicz
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug...
03/18/2026
The Dermatologist
FDA Alerts
FDA Approves Cosentyx for the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate-To-Severe Hidradenitis Suppurativa
03/17/2026
Jessica Garlewicz
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug...
03/17/2026
The Dermatologist
atopic dermatitis
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
FDA Alerts
FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis
03/10/2026
Jessica Garlewicz
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food...
03/10/2026
The Dermatologist
psoriasis
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
Cutaneous Squamous Cell Carcinoma
News
Managing Cutaneous Squamous Cell Carcinoma
01/06/2026
Jessica Garlewicz
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review...
01/06/2026
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Roflumilast Cream 0.05% for Treatment of Atopic Dermatitis in Children Aged 2 to 5
10/06/2025
Riya Gandhi, MA
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA...
10/06/2025
The Dermatologist

Endorsed Articles

Partner Approved
Unilateral Linear Psoriasis: A Case Report
05/13/2020
Sonya Zarkhin, DO; Sean Stephenson, DO
A 19-year-old white woman with a 4-year history of a rash localized to her left arm and hand. The lesion started as a small plaque on her forearm and gradually spread in a linear fashion from her fingertip to her upper arm.
A 19-year-old white woman with a 4-year history of a rash localized to her left arm and hand. The lesion started as a small plaque on her forearm and gradually spread in a linear fashion from her fingertip to her upper arm.
A 19-year-old white woman with a...
05/13/2020
The Dermatologist
Partner Approved
Disease Management and Patient Care Recommendations During the COVID-19 Pandemic
04/14/2020
Lauren Mateja
Patients with psoriasis and psoriatic arthritis have increased calls to their dermatologist for advice on continuance of their therapy during uncertain times. Guidance from national organizations provide answers that dermatologists can pass...
Patients with psoriasis and psoriatic arthritis have increased calls to their dermatologist for advice on continuance of their therapy during uncertain times. Guidance from national organizations provide answers that dermatologists can pass...
Patients with psoriasis and...
04/14/2020
The Dermatologist
NPF Endorsed Features
Options With IL-23 Inhibitors for the Patient With Psoriasis
03/12/2020
Lauren Mateja
New and emerging therapies such as biologics continue to improve quality of life and outcomes for patients with psoriasis. Biologics that block IL-23 functions present a unique opportunity to provide long-term, effective treatment.
New and emerging therapies such as biologics continue to improve quality of life and outcomes for patients with psoriasis. Biologics that block IL-23 functions present a unique opportunity to provide long-term, effective treatment.
New and emerging therapies such...
03/12/2020
The Dermatologist
Partner Approved
Management of Psoriasis in Adolescents
01/16/2020
Lauren Mateja
Psoriasis can affect patients at all walks of life, from children to the elderly. Adolescents, however, require special considerations, from psychosocial conditions to therapy options, for the short- and long-term...
Psoriasis can affect patients at all walks of life, from children to the elderly. Adolescents, however, require special considerations, from psychosocial conditions to therapy options, for the short- and long-term...
...
01/16/2020
The Dermatologist
NPF Endorsed Features
Position Statement: Routine TB Testing for IL-17 and IL-23 Inhibitors
01/30/2026
Lisa Kuhns, PhD, MD
A new NPF Medical Board/International Psoriasis Council joint position statement concludes that routine latent tuberculosis infection testing is unnecessary for patients with psoriasis who are taking IL-17 or IL-23 inhibitors.
A new NPF Medical Board/International Psoriasis Council joint position statement concludes that routine latent tuberculosis infection testing is unnecessary for patients with psoriasis who are taking IL-17 or IL-23 inhibitors.
A new NPF Medical...
01/30/2026
The Dermatologist
NPF Endorsed Features
Psoriatic Disease and the Domino Effect of Comorbidities
10/06/2025
Lisa Kuhns, PhD, MD
Research has consistently shown that people with psoriasis and psoriatic arthritis face higher rates of serious comorbidities
Research has consistently shown that people with psoriasis and psoriatic arthritis face higher rates of serious comorbidities
Research has consistently shown...
10/06/2025
The Dermatologist
NPF Endorsed Features
Salon to Skin: How Dermatologists and Hair Stylists Can Work Together
08/02/2025
Samantha Schlosser
With a passion for hair loss and ethnic skin, Dr Chesahna Kindred is bridging the gap between beauty and medicine through the S.T.R.A.N.D. Network.
With a passion for hair loss and ethnic skin, Dr Chesahna Kindred is bridging the gap between beauty and medicine through the S.T.R.A.N.D. Network.
With a passion for hair loss and...
08/02/2025
The Dermatologist
NPF Endorsed Features
Missouri’s Call, ECHO’s Answer: Expanding Access to Psoriasis Care
05/01/2025
Demi Elord, MS-II; Shivani Jain, MSIV
With continued innovation, Extension for Community Healthcare Outcomes programs have the potential to revolutionize psoriasis treatment, improving outcomes and bringing expert care closer to those who need it most.
With continued innovation, Extension for Community Healthcare Outcomes programs have the potential to revolutionize psoriasis treatment, improving outcomes and bringing expert care closer to those who need it most.
With continued innovation,...
05/01/2025
The Dermatologist
NPF Endorsed Features
Highlights From the 2024 Psoriasis Health Indicator Report
02/03/2025
Lisa Kuhns, PhD, MD
The National Psoriasis Foundation’s first-ever health indicator report takes a deep dive into the health burden of psoriatic disease, treatment gaps, and future directions in care.
The National Psoriasis Foundation’s first-ever health indicator report takes a deep dive into the health burden of psoriatic disease, treatment gaps, and future directions in care.
The National Psoriasis...
02/03/2025
The Dermatologist
NPF Endorsed Features
Reexamining Remission in Psoriasis
10/07/2024
Jess Smith, BS
Results from a recent study can inform future efforts to develop or modify definitions of remission for the psoriatic disease community.
Results from a recent study can inform future efforts to develop or modify definitions of remission for the psoriatic disease community.
Results from a recent study can...
10/07/2024
The Dermatologist
NPF Endorsed Features
Phone-a-Friend: Exploring the Collaborative Care Model in Psoriasis
08/06/2024
Samantha Koons
The multifaceted nature of psoriatic disease may require multiple providers from different disciplines or specialties for optimal patient care.
The multifaceted nature of psoriatic disease may require multiple providers from different disciplines or specialties for optimal patient care.
The multifaceted nature of...
08/06/2024
The Dermatologist
NPF Endorsed Features
What’s New in Psoriasis Research
05/03/2024
Jessica Garlewicz; Riya Gandhi, MA
Keep up-to-date with this roundup of recent studies.
Keep up-to-date with this roundup of recent studies.
Keep up-to-date with this...
05/03/2024
The Dermatologist
NPF Endorsed Features
The Mental Health and Psoriatic Disease Connection
02/07/2024
Samip Sheth, MD
A recent National Psoriasis Foundation webinar explores the link between psychiatric comorbidities and skin conditions.
A recent National Psoriasis Foundation webinar explores the link between psychiatric comorbidities and skin conditions.
A recent National Psoriasis...
02/07/2024
The Dermatologist
NPF Endorsed Features
Understanding Generalized Pustular Psoriasis
12/05/2023
Jessica Garlewicz
Proper evaluation and history collection are essential for accurate diagnosis and timely treatment.
Proper evaluation and history collection are essential for accurate diagnosis and timely treatment.
Proper evaluation and history...
12/05/2023
The Dermatologist

Quizzes and Polls

psoriasis
Quiz
Long-Term Safety of Risankizumab
10/18/2024
Jessica Garlewicz
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings...
10/18/2024
The Dermatologist
psoriatic arthritis on hand
Quiz
Trivia: Treatment Improves Health-Related Quality of Life in Patients With Psoriatic Arthritis
08/03/2022
Jessica Garlewicz
Which treatment improved health-related quality of life, fatigue, pain, and work productivity in adults with active psoriatic arthritis?
Which treatment improved health-related quality of life, fatigue, pain, and work productivity in adults with active psoriatic arthritis?
Which treatment improved...
08/03/2022
The Dermatologist
psoriasis on hand and stomach
Quiz
Trivia: Risankizumab Comparable Safety and Efficacy Profiles in Psoriasis
06/15/2022
Jessica Garlewicz
Risankizumab’s efficacy and safety profile is faster than another anti-IL23 when treating which of these options?
Risankizumab’s efficacy and safety profile is faster than another anti-IL23 when treating which of these options?
Risankizumab’s efficacy and...
06/15/2022
The Dermatologist
psoriasis generalized pustular
Quiz
Trivia: Psoriasis Treatment Perspectives and Expectations
05/18/2022
Jessica Garlewicz
Which of these options list the characteristics that impact treatment goals for patients with psoriasis?
Which of these options list the characteristics that impact treatment goals for patients with psoriasis?
Which of these options list the...
05/18/2022
The Dermatologist
psoriasis severe arm
Quiz
Trivia: Psoriasis and Stress Coping Strategies
04/05/2022
Jessica Garlewicz
Which of the following is impacted by psoriasis and stress coping strategies ?
Which of the following is impacted by psoriasis and stress coping strategies ?
Which of the following is...
04/05/2022
The Dermatologist
psoriasis-severe
Quiz
Trivia: Unmet Needs in Psoriasis
12/02/2021
Which of the following accurately highlights what unmet needs were reported by patients with mild-to-moderate psoriasis?
Which of the following accurately highlights what unmet needs were reported by patients with mild-to-moderate psoriasis?
Which of the following...
12/02/2021
The Dermatologist
Severe psoriasis, such as plaque psoriasis shown here, can benefit from biologic agents that enable psoriasis treatment.
Quiz
Trivia: Efficacy of Biologic Agents
10/05/2021
Can you identify how dermatologists can observe the efficacy of biologic agents on the full psoriasis disease burden?
Can you identify how dermatologists can observe the efficacy of biologic agents on the full psoriasis disease burden?
Can you identify how...
10/05/2021
The Dermatologist
Patient with psoriasis on the scalp. Recent studies have looked into hypochondriasis in psoriasis such as this patient.
Quiz
Trivia: Hypochondriasis and Personality Traits in PsO
09/09/2021
An observational study of patients with psoriasis sought to assess hypochondriasis and personality traits. Can you identify which of these options describes their findings?
An observational study of patients with psoriasis sought to assess hypochondriasis and personality traits. Can you identify which of these options describes their findings?
An observational study of...
09/09/2021
The Dermatologist
A patient suffering from obesity showcasing a case of plaque psoriasis in a potential risk for cardiovascular disease.
Quiz
Trivia: Measuring Arterial Function in Patients with Psoriasis
08/26/2021
Identify what noninvasive measurement of arterial function was performed on patients with chronic plaque psoriasis to determine cardiovascular risk.
Identify what noninvasive measurement of arterial function was performed on patients with chronic plaque psoriasis to determine cardiovascular risk.
Identify what noninvasive...
08/26/2021
The Dermatologist
pediatric psoriasis pictures severe psoriasis on knees
Quiz
Trivia: Pediatric Psoriasis Comorbidities
08/23/2021
Which of these options accurately portrays the common comorbidities observed within pediatric patients with psoriasis?
Which of these options accurately portrays the common comorbidities observed within pediatric patients with psoriasis?
Which of these options...
08/23/2021
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist
Quiz
Early Intervention Strategies in Pediatric Atopic Dermatitis
02/26/2026
Riya Gandhi, MA
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of...
02/26/2026
The Dermatologist
Quiz
Air Pollution and Atopic Disease: Evaluating Epidemiologic Evidence
02/26/2026
Riya Gandhi, MA
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the...
02/26/2026
The Dermatologist
Quiz
Clinical Trial Evaluation of Eyebrow and Eyelash Regrowth in AA
02/05/2026
Riya Gandhi, MA
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how...
02/05/2026
The Dermatologist
cover March 2026

Current Issue

March 2026
Volume 34
Issue 2
Current Issue
Issue Archive

Recent News

psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
psoriasis
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
psoriasis
News
Study Links Hypothyroidism to Psoriasis, Independent of Disease Severity
09/02/2025
Jessica Garlewicz
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that...
09/02/2025
The Dermatologist
psoriasis
News
Beta-Blockers Not Linked to Increased Psoriasis Risk, Study Finds
09/02/2025
Jessica Garlewicz
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis...
09/02/2025
The Dermatologist
psoriasis
News
Study Finds Distinct Psychosocial Burdens in Early- vs Late-Onset Psoriasis
08/14/2025
Jessica Garlewicz
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study...
08/14/2025
The Dermatologist
psoriasis
News
Study Highlights Emerging Role of Stem Cells in Psoriasis Pathogenesis
08/14/2025
Jessica Garlewicz
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally...
08/14/2025
The Dermatologist
psoriasis
News
Comorbidity Patterns in Moderate-to-Severe Psoriasis Highlight Need for Integrated Clinical Management
07/22/2025
Jessica Garlewicz
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity...
07/22/2025
The Dermatologist
psoriasis
News
Early Use of Biologics in Psoriasis May Alter Inflammatory Course, Improve Comorbidities
07/10/2025
Jessica Garlewicz
As the understanding of psoriasis pathophysiology continues to evolve, treatment goals may need to expand accordingly.
As the understanding of psoriasis pathophysiology continues to evolve, treatment goals may need to expand accordingly.
As the understanding of...
07/10/2025
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
FDA Alerts
FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients
03/18/2026
Jessica Garlewicz
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug...
03/18/2026
The Dermatologist
FDA Alerts
FDA Approves Cosentyx for the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate-To-Severe Hidradenitis Suppurativa
03/17/2026
Jessica Garlewicz
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug...
03/17/2026
The Dermatologist
atopic dermatitis
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
FDA Alerts
FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis
03/10/2026
Jessica Garlewicz
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food...
03/10/2026
The Dermatologist
psoriasis
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
Cutaneous Squamous Cell Carcinoma
News
Managing Cutaneous Squamous Cell Carcinoma
01/06/2026
Jessica Garlewicz
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review...
01/06/2026
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Roflumilast Cream 0.05% for Treatment of Atopic Dermatitis in Children Aged 2 to 5
10/06/2025
Riya Gandhi, MA
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA...
10/06/2025
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use